{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T19:04:52Z","timestamp":1792436692589,"version":"4.5.0"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T00:00:00Z","timestamp":1233619200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1038\/ncpneph1040","type":"journal-article","created":{"date-parts":[[2009,2,3]],"date-time":"2009-02-03T19:16:04Z","timestamp":1233688564000},"page":"157-170","source":"Crossref","is-referenced-by-count":66,"title":["Skin problems in chronic kidney disease"],"prefix":"10.1038","volume":"5","author":[{"given":"Dirk RJ","family":"Kuypers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,2,3]]},"reference":[{"key":"BFncpneph1040_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4103\/0378-6323.25636","volume":"72","author":"P Udayakumar","year":"2006","unstructured":"Udayakumar P et al. (2006) Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 72: 119\u2013125","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"BFncpneph1040_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1034\/j.1600-0560.2003.00109.x","volume":"30","author":"M Abdelbaqi-Salhab","year":"2003","unstructured":"Abdelbaqi-Salhab M et al. (2003) A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 30: 527\u2013538","journal-title":"J Cutan Pathol"},{"key":"BFncpneph1040_CR3","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1067\/mjd.2000.110651","volume":"43","author":"L Robinson-Bostom","year":"2000","unstructured":"Robinson-Bostom L et al. (2000) Cutaneous manifestations of end-stage renal disease. J Am Acad Dermatol 43: 975\u2013986","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.ajkd.2007.03.010","volume":"50","author":"TS Patel","year":"2007","unstructured":"Patel TS et al. (2007) An update on pruritus associated with CKD. Am J Kidney Dis 50: 11\u201320","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR5","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1093\/ndt\/gfl461","volume":"21","author":"RL Pisoni","year":"2006","unstructured":"Pisoni RL et al. (2006) Pruritus in haemodialysis patients: International results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 21: 3495\u20133505","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR6","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1468-3083.2006.01570.x","volume":"20","author":"S Mistik","year":"2006","unstructured":"Mistik S et al. (2006) An epidemiology study of patients with uremic pruritus. J Eur Acad Dermatol Venereol 20: 672\u2013678","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFncpneph1040_CR7","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-4632.2005.02592.x","volume":"45","author":"P Dyachenko","year":"2006","unstructured":"Dyachenko P et al. (2006) Hemodialysis-related pruritus and associated cutaneous manifestations. Int J Dermatol 45: 664\u2013667","journal-title":"Int J Dermatol"},{"key":"BFncpneph1040_CR8","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/sj.ki.5002197","volume":"72","author":"SR Keith-Reddy","year":"2007","unstructured":"Keith-Reddy SR et al. (2007) Uremic pruritus. Kidney Int 72: 373\u2013377","journal-title":"Kidney Int"},{"key":"BFncpneph1040_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1525-1594.2008.00568.x","volume":"32","author":"HH Lin","year":"2008","unstructured":"Lin HH et al. (2008) Uremic pruritus, cytokines, and polymethylmethacrylate artificial kidney. Artif Organs 32: 468\u2013472","journal-title":"Artif Organs"},{"key":"BFncpneph1040_CR10","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1038\/sj.ki.5000251","volume":"69","author":"I Narita","year":"2006","unstructured":"Narita I et al. (2006) Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients. Kidney Int 69: 1626\u20131632","journal-title":"Kidney Int"},{"key":"BFncpneph1040_CR11","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1046\/j.1365-2567.1999.00801.x","volume":"97","author":"J Garssen","year":"1999","unstructured":"Garssen J et al. (1999) UVB exposure-induced systemic modulation of TH1- and TH2-mediated immune responses. Immunology 97: 506\u2013514","journal-title":"Immunology"},{"key":"BFncpneph1040_CR12","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ndt\/gfi204","volume":"21","author":"M Kimmel","year":"2006","unstructured":"Kimmel M et al. (2006) The role of micro-inflammation in the pathogenesis of uremic pruritus in haemodialysis patients. Nephrol Dial Transplant 21: 749\u2013755","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl","key":"BFncpneph1040_CR13","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1681\/ASN.V13suppl_1s28","volume":"13","author":"AR Qureshi","year":"2002","unstructured":"Qureshi AR et al. (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13 (Suppl): S28\u2013S36","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph1040_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","volume":"477","author":"H Umueuchi","year":"2003","unstructured":"Umueuchi H et al. (2003) Involvement of central \u00b5-opioid system in the scratching behavior in mice, and the suppression of itch by the activation of \u00b5-opioid system. Eur J Pharmacol 477: 29\u201335","journal-title":"Eur J Pharmacol"},{"key":"BFncpneph1040_CR15","first-page":"279","volume-title":"Itch, Basic Mechanisms and Therapy","author":"H Kumagai","year":"2004","unstructured":"Kumagai H et al. (2004) Prospects for a novel kappa-opioid receptor agonist, TRK-820, in uremic pruritus. In Itch, Basic Mechanisms and Therapy, 279\u2013286 (Eds Yosipovitch G et al.) New York, NY: Dekker"},{"key":"BFncpneph1040_CR16","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.1681\/ASN.2005020152","volume":"16","author":"B Wikstr\u00f6m","year":"2005","unstructured":"Wikstr\u00f6m B et al. (2005) Kappa-opioid system in uremic pruritus: multicenter, randomized, double-blind, placebo-controlled clinical studies. J Am Soc Nephrol 16: 3742\u20133747","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph1040_CR17","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","volume":"348","author":"G Peer","year":"1996","unstructured":"Peer G et al. (1996) Randomised cross-over-trial of naltrexone in uraemic pruritus. Lancet 348: 1552\u20131554","journal-title":"Lancet"},{"key":"BFncpneph1040_CR18","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S0190-9622(97)70240-8","volume":"36","author":"YL Cho","year":"1997","unstructured":"Cho YL et al. (1997) Uremic pruritus: roles of parathyroid hormone and substance P. J Am Acad Dermatol 36: 538\u2013543","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR19","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S1072-7515(99)00212-4","volume":"190","author":"FF Chou","year":"2000","unstructured":"Chou FF et al. (2000) A study on pruritus after parathyroidectomy for secondary hyperparathyroidism. J Am Coll Surg 190: 65\u201370","journal-title":"J Am Coll Surg"},{"key":"BFncpneph1040_CR20","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1093\/ndt\/gfh287","volume":"19","author":"A Momose","year":"2004","unstructured":"Momose A et al. (2004) Calciums ions are abnormally distributed in the skin of haemodialysis patients with uraemic pruritus. Nephrol Dial Transplant 19: 2061\u20132066","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 1","key":"BFncpneph1040_CR21","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1007\/BF01674408","volume":"44","author":"J Szepietowski","year":"1995","unstructured":"Szepietowski J et al. (1995) Pruritus and mast cell proliferation in the skin of haemodialysis patients. Inflamm Res 44 (Suppl 1): S84\u2013S85","journal-title":"Inflamm Res"},{"key":"BFncpneph1040_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/j.1610-0387.2005.05706.x","volume":"3","author":"S Dugas-Breit","year":"2005","unstructured":"Dugas-Breit S et al. (2005) Baseline serum levels of mast cell tryptase are raised in hemodialysis patients and associated with severity of pruritus. J Dtsch Dermatol Ges 3: 343\u2013347","journal-title":"J Dtsch Dermatol Ges"},{"key":"BFncpneph1040_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000044967","volume":"78","author":"EV Balaskas","year":"1998","unstructured":"Balaskas EV et al. (1998) Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients. Nephron 78: 395\u2013402","journal-title":"Nephron"},{"key":"BFncpneph1040_CR24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S0272-6386(00)70251-4","volume":"35","author":"SD Ashmore","year":"2000","unstructured":"Ashmore SD et al. (2000) Ondansetron therapy for uremic pruritus in hemodialysis patients. Am J Kidney Dis 35: 827\u2013831","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2340\/0001555572102105","volume":"72","author":"F Fantini","year":"1992","unstructured":"Fantini F et al. (1992) Cutaneous innervation in chronic renal failure patients: an immunohistochemical study. Acta Derm Venereol 72: 102\u2013105","journal-title":"Acta Derm Venereol"},{"key":"BFncpneph1040_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/0304-3940(89)90460-6","volume":"99","author":"O Johansson","year":"1989","unstructured":"Johansson O et al. (1989) Intra-epidermal neuron-specific enolase (NSE)-immunoreactive nerve fibres: evidence for sprouting in uremic patients on maintenance hemodialysis. Neurosci Lett 99: 281\u2013286","journal-title":"Neurosci Lett"},{"key":"BFncpneph1040_CR27","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1093\/oxfordjournals.ndt.a027092","volume":"11","author":"CA Morton","year":"1996","unstructured":"Morton CA et al. (1996) Pruritus and skin hydration during dialysis. Nephrol Dial Transplant 11: 2031\u20132036","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR28","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1526-0968.2004.00175.x","volume":"8","author":"K Okada","year":"2004","unstructured":"Okada K et al. (2004) Effect of skin care with an emollient containing a high water content on mild uremic pruritus. Ther Apher Dial 8: 419\u2013422","journal-title":"Ther Apher Dial"},{"key":"BFncpneph1040_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/j.ajkd.2006.03.082","volume":"48","author":"YC Chen","year":"2006","unstructured":"Chen YC et al. (2006) Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus. Am J Kidney Dis 48: 69\u201376","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/09546639609089555","volume":"7","author":"F Wasik","year":"1996","unstructured":"Wasik F et al. (1996) Relief of uraemic pruritus after balneological therapy with a bath oil containing polidocanol (Balneum Hernal Plus): an open clinical study. J Dermatol Treat 7: 231\u2013233","journal-title":"J Dermatol Treat"},{"key":"BFncpneph1040_CR31","first-page":"97","volume":"13","author":"JC Szepietowski","year":"2005","unstructured":"Szepietowski JC et al. (2005) Efficacy and tolerance of the cream containing structured physiological lipids with endocannabinoids in the treatment of uremic pruritus: a preliminary study. Acta Dermatovenerol Croat 13: 97\u2013103","journal-title":"Acta Dermatovenerol Croat"},{"key":"BFncpneph1040_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0190-9622(92)70013-6","volume":"26","author":"DL Breneman","year":"1992","unstructured":"Breneman DL et al. (1992) Topical capsaicin for the treatment of hemodialysis-related pruritus. Am Acad Dermatol 26: 91\u201394","journal-title":"Am Acad Dermatol"},{"key":"BFncpneph1040_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1159\/000188949","volume":"72","author":"DC Tarng","year":"1996","unstructured":"Tarng DC et al. (1996) Hemodialysis-related pruritus: a double-blind, placebo-controlled, cross-over study of capsaicin 0.025% cream. Nephron 72: 617\u2013622","journal-title":"Nephron"},{"key":"BFncpneph1040_CR34","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1093\/ndt\/gfh202","volume":"19","author":"DK Kuypers","year":"2004","unstructured":"Kuypers DK et al. (2004) A prospective proof of concept study of the efficacy of tacrolimus ointment on uremic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 19: 1895\u20131901","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR35","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaad.2004.08.050","volume":"52","author":"MI Duque","year":"2005","unstructured":"Duque MI et al. (2005) Lack of efficacy of tacrolimus ointment 0.1% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J Am Acad Dermatol 52: 519\u2013521","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR36","unstructured":"US Food and Drug Administration (online 10 March 2005) FDA Public Health Advisory: Elidel (pimecrolimus) cream and Protopic (tacrolimus) ointment. [ www.fda.gov\/medwatch\/SAFETY\/2005\/safety05.htm#Elidel ] (accessed 2 January 2009)"},{"key":"BFncpneph1040_CR37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/09546630510041088","volume":"16","author":"M Naylor","year":"2005","unstructured":"Naylor M et al. (2005) Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus. J Dermatolog Treat 16: 149\u2013153","journal-title":"J Dermatolog Treat"},{"key":"BFncpneph1040_CR38","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1592\/phco.27.7.1020","volume":"27","author":"PJ Munzenberger","year":"2007","unstructured":"Munzenberger PJ et al. (2007) Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Pharmacotherapy 27: 1020\u20131028","journal-title":"Pharmacotherapy"},{"key":"BFncpneph1040_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.7326\/0003-4819-91-1-17","volume":"91","author":"BA Gilchrest","year":"1979","unstructured":"Gilchrest BA et al. (1979) Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 91: 17\u201321","journal-title":"Ann Intern Med"},{"key":"BFncpneph1040_CR40","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jaad.2004.12.052","volume":"53","author":"S Ada","year":"2005","unstructured":"Ada S et al. (2005) Treatment of uremic pruritus with narrowband ultraviolet B phototherapy: an open pilot study. J Am Acad Dermatol 53: 149\u2013151","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR41","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-4632.2007.03048.x","volume":"46","author":"D Seckin","year":"2007","unstructured":"Seckin D et al. (2007) Generalized pruritus treated with narrowband UVB. Int J Dermatol 46: 367\u2013370","journal-title":"Int J Dermatol"},{"key":"BFncpneph1040_CR42","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","volume":"19","author":"AI Gunal","year":"2004","unstructured":"Gunal AI et al. (2004) Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 19: 3137\u20133139","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR43","first-page":"86","volume":"18","author":"L Manenti","year":"2005","unstructured":"Manenti L et al. (2005) Gabapentin in the treatment of uremic itch: an index case and pilot evaluation. J Nephrol 18: 86\u201391","journal-title":"J Nephrol"},{"key":"BFncpneph1040_CR44","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1681\/ASN.V113514","volume":"11","author":"C Pauli-Magnus","year":"2000","unstructured":"Pauli-Magnus C et al. (2000) Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J Am Soc Nephrol 11: 514\u2013519","journal-title":"J Am Soc Nephrol"},{"key":"BFncpneph1040_CR45","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0923-1811(03)00132-4","volume":"33","author":"A Imaizumi","year":"2003","unstructured":"Imaizumi A et al. (2003) Effective treatment of pruritus on atopic dermatitis using H1 antihistamines (second-generation antihistamines): changes in blood histamine and tryptase levels. J Dermatol Sci 33: 23\u201329","journal-title":"J Dermatol Sci"},{"key":"BFncpneph1040_CR46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.7326\/0003-4819-93-3-446","volume":"93","author":"JA Pederson","year":"1980","unstructured":"Pederson JA et al. (1980) Relief of idiopatic generalized pruritus in dialysis patients treated with activated oral charcoal. Ann Intern Med 93: 446\u2013448","journal-title":"Ann Intern Med"},{"key":"BFncpneph1040_CR47","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000188582","volume":"70","author":"S Giovannetti","year":"1995","unstructured":"Giovannetti S et al. (1995) Oral activated charcoal in patients with uremic pruritus. Nephron 70: 193\u2013196","journal-title":"Nephron"},{"key":"BFncpneph1040_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.4103\/0378-6323.32887","volume":"73","author":"P Layegh","year":"2007","unstructured":"Layegh P et al. (2007) Effect of oral granisetron in uremic pruritus. Indian J Dermatol Venereol Leprol 73: 231\u2013234","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"BFncpneph1040_CR49","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1159\/000187978","volume":"67","author":"SR Silva","year":"1994","unstructured":"Silva SR et al. (1994) Thalidomide for the treatment of uremic pruritus: a crossover randomized double-blind trial. Nephron 67: 270\u2013273","journal-title":"Nephron"},{"key":"BFncpneph1040_CR50","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1056\/NEJM199204093261501","volume":"326","author":"S De Marchi","year":"1992","unstructured":"De Marchi S et al. (1992) Relief of pruritus and decreases in plasma histamine concentrations during erythropoietin therapy in patients with uremia. N Engl J Med 326: 969\u2013974","journal-title":"N Engl J Med"},{"key":"BFncpneph1040_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/S0272-6386(00)70003-5","volume":"35","author":"DT Janigan","year":"2000","unstructured":"Janigan DT et al. (2000) Calcified subcutaneous arterioles with infarcts of the subcutis and skin (\u201ccalciphylaxis\u201d) in chronic renal failure. Am J Kidney Dis 35: 588\u2013597","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR52","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1046\/j.1525-139X.2002.00052.x","volume":"15","author":"W Wilmer","year":"2002","unstructured":"Wilmer W et al. (2002) Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 15: 172\u2013186","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR53","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.jaad.2006.08.065","volume":"56","author":"RH Weenig","year":"2007","unstructured":"Weenig RH et al. (2007) Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 56: 569\u2013579","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR54","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1525-139X.2007.00263.x","volume":"20","author":"NM Rogers","year":"2007","unstructured":"Rogers NM et al. (2007) Calcific uremic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 20: 150\u2013157","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1046\/j.1523-1755.2001.00803.x","volume":"60","author":"AR Mazhar","year":"2001","unstructured":"Mazhar AR et al. (2001) Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney Int 60: 324\u2013332","journal-title":"Kidney Int"},{"key":"BFncpneph1040_CR56","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1309\/AGLF-X21H-Y37W-50KL","volume":"113","author":"LR Essary","year":"2000","unstructured":"Essary LR et al. (2000) Cutaneous calciphylaxis: an underrecognized clinicopathologic entity. Am J Clin Pathol 113: 280\u2013287","journal-title":"Am J Clin Pathol"},{"key":"BFncpneph1040_CR57","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1053\/j.ajkd.2006.05.031","volume":"48","author":"W Bleibel","year":"2006","unstructured":"Bleibel W et al. (2006) A case report comparing various radiological tests in the diagnosis of calcific uremic arteriolopathy. Am J Kidney Dis 48: 659\u2013661","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR58","first-page":"797","volume":"37","author":"WA Wilmer","year":"2001","unstructured":"Wilmer WA et al. (2001) Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis 37: 797\u2013806","journal-title":"Dis"},{"key":"BFncpneph1040_CR59","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/RLU.0b013e31817792e4","volume":"33","author":"S Soni","year":"2008","unstructured":"Soni S et al. (2008) Bone scan findings in metastatic calcification from calciphylaxis. Clin Nucl Med 33: 502\u2013504","journal-title":"Clin Nucl Med"},{"key":"BFncpneph1040_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1525-139X.2007.00255.x","volume":"20","author":"RX Shroff","year":"2007","unstructured":"Shroff RX et al. (2007) The vascular biology of calcification. Semin Dial 20: 103\u2013109","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR61","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaad.2007.12.006","volume":"58","author":"RH Weenig","year":"2008","unstructured":"Weenig RH (2008) Pathogenesis of calciphylaxis: Hans Selye to nuclear factor \u03baB. J Am Acad Dermatol 58: 458\u2013471","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR62","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00467-003-1276-0","volume":"18","author":"SM Moe","year":"2003","unstructured":"Moe SM et al. (2003) Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis. Pediatr Nephrol 18: 969\u2013975","journal-title":"Pediatr Nephrol"},{"key":"BFncpneph1040_CR63","first-page":"728","volume":"16","author":"W Griethe","year":"2003","unstructured":"Griethe W et al. (2003) Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis. J Nephrol 16: 728\u2013732","journal-title":"J Nephrol"},{"key":"BFncpneph1040_CR64","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1053\/ajkd.2001.24533","volume":"37","author":"S Ahmed","year":"2001","unstructured":"Ahmed S et al. (2001) Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 37: 1267\u20131276","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR65","doi-asserted-by":"publisher","first-page":"E686","DOI":"10.1152\/ajpendo.00552.2003","volume":"286","author":"R Vattikuti","year":"2004","unstructured":"Vattikuti R et al. (2004) Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab 286: E686\u2013E696","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"BFncpneph1040_CR66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1172\/JCI17202","volume":"112","author":"C Schafer","year":"2003","unstructured":"Schafer C et al. (2003) The serum protein \u03b12-Heremans-Schmid glycoprotein\/fetuin-A is a systemically acting inhibitor of ectopy calcification. J Clin Invest 112: 357\u2013366","journal-title":"J Clin Invest"},{"key":"BFncpneph1040_CR67","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000124863","volume":"45","author":"EC Cranenburg","year":"2008","unstructured":"Cranenburg EC et al. (2008) The circulating inactive form of Matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification. J Vasc Res 45: 427\u2013436","journal-title":"J Vasc Res"},{"key":"BFncpneph1040_CR68","doi-asserted-by":"publisher","first-page":"380","DOI":"10.2310\/6650.2006.06017","volume":"54","author":"NX Chen","year":"2006","unstructured":"Chen NX et al. (2006) Uremic vascular calcifications. J Investig Med 54: 380\u2013384","journal-title":"J Investig Med"},{"key":"BFncpneph1040_CR69","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1067\/msy.2001.117101","volume":"130","author":"JA Girotto","year":"2001","unstructured":"Girotto JA et al. (2001) Parathyroidectomy promotes wound healing and prolongs survival in patients with calciphylaxis from secondary hyperparathyroidism. Surgery 130: 645\u2013651","journal-title":"Surgery"},{"key":"BFncpneph1040_CR70","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1365-4632.2005.02169.x","volume":"44","author":"RL Galimberti","year":"2005","unstructured":"Galimberti RL et al. (2005) Cutaneous necrosis by calcific uremic arteriolopathy. Int J Dermatol 44: 101\u2013106","journal-title":"Int J Dermatol"},{"key":"BFncpneph1040_CR71","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1093\/ndt\/gfl114","volume":"21","author":"N Velasco","year":"2006","unstructured":"Velasco N et al. (2006) Successful treatment of calciphylaxis with cinacalcet\u2014an alternative to parathyroidectomy? Nephrol Dial Transplant 21: 1999\u20132004","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR72","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1093\/ndt\/gfh825","volume":"20","author":"G Guerra","year":"2005","unstructured":"Guerra G et al. (2005) Rapid resolution of calciphylaxis with intravenous sodium thiosulfate and continuous venovenous haemofiltration using low calcium replacement fluid: case report. Nephrol Dial Transplant 20: 1260\u20131262","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR73","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000100877","volume":"214","author":"M Meissner","year":"2007","unstructured":"Meissner M et al. (2007) Sodium thiosulfate: a new way of treatment for calciphylaxis? Dermatology 214: 278\u2013282","journal-title":"Dermatology"},{"key":"BFncpneph1040_CR74","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/08860220600583781","volume":"28","author":"D Mataic","year":"2006","unstructured":"Mataic D et al. (2006) Intraperitoneal sodium thiosulfate for the treatment of calciphylaxis. Ren Fail 28: 361\u2013363","journal-title":"Ren Fail"},{"key":"BFncpneph1040_CR75","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1053\/j.ajkd.2006.04.062","volume":"48","author":"N Shiraishi","year":"2006","unstructured":"Shiraishi N et al. (2006) Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) by etidronate sodium. Am J Kidney Dis 48: 151\u2013154","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR76","doi-asserted-by":"crossref","unstructured":"da Costa JB et al. (2007) Pamidronate as a treatment option in calciphylaxis. J Eur Acad Dermatol Venereol [10.1111\/j.1468-3083.2007.02532.x]","DOI":"10.1111\/j.1468-3083.2007.02532.x"},{"key":"BFncpneph1040_CR77","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jaad.2007.06.029","volume":"57","author":"T Hanafusa","year":"2007","unstructured":"Hanafusa T et al. (2007) Intractable wounds caused by calcific uremic arteriolopathy treated with bisphosphonates. J Am Acad Dermatol 57: 1021\u20131025","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR78","first-page":"676","volume":"15","author":"C Basile","year":"2002","unstructured":"Basile C et al. (2002) Hyperbaric oxygen therapy for calcific uremic arteriolopathy: a case series. J Nephrol 15: 676\u2013680","journal-title":"J Nephrol"},{"key":"BFncpneph1040_CR79","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","volume":"35","author":"FA Mendoza","year":"2006","unstructured":"Mendoza FA et al. (2006) Description of twelve cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35: 238\u2013249","journal-title":"Semin Arthritis Rheum"},{"key":"BFncpneph1040_CR80","unstructured":"The International Center for Nephrogenic Fibrosing Dermopathy Research (ICNFDR) [ http:\/\/www.icnfdr.org\/ ] (accessed 2 January 2009)"},{"key":"BFncpneph1040_CR81","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1525-139X.2006.00152.x","volume":"19","author":"DM DeHoratius","year":"2006","unstructured":"DeHoratius DM et al. (2006) Nephrogenic systemic fibrosis: an emerging threat among renal patients. Semin Dial 19: 191\u2013194","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR82","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/ndt\/gfg506","volume":"19","author":"P Evenepoel","year":"2004","unstructured":"Evenepoel P et al. (2004) Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 19: 469\u2013473","journal-title":"Nephrol Dial Transplant"},{"key":"BFncpneph1040_CR83","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/archderm.140.11.1401","volume":"140","author":"A Fazeli","year":"2004","unstructured":"Fazeli A et al. (2004) Nephrogenic fibrosing dermopathy: are ACE inhibitors the missing link? Arch Dermatol 140: 1401","journal-title":"Arch Dermatol"},{"key":"BFncpneph1040_CR84","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2214\/AJR.07.2822","volume":"190","author":"CD Wiginton","year":"2008","unstructured":"Wiginton CD et al. (2008) Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 190: 1060\u20131068","journal-title":"AJR Am J Roentgenol"},{"key":"BFncpneph1040_CR85","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7326\/0003-4819-145-3-200608010-00021","volume":"145","author":"S Swaminathan","year":"2006","unstructured":"Swaminathan S et al. (2006) Nephrogenic fibrosing dermopathy and high-dose erythropoietin therapy. Ann Intern Med 145: 234\u2013235","journal-title":"Ann Intern Med"},{"key":"BFncpneph1040_CR86","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.ejrad.2008.02.011","volume":"66","author":"DR Broome","year":"2008","unstructured":"Broome DR (2008) Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Eur J Radiol 66: 230\u2013234","journal-title":"Eur J Radiol"},{"key":"BFncpneph1040_CR87","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2215\/CJN.00030107","volume":"2","author":"MA Perazella","year":"2007","unstructured":"Perazella MA (2007) Nephrogenic systemic fibrosis, kidney disease and gadolinium: is there a link? Clin J Am Soc Nephrol 2: 200\u2013202","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph1040_CR88","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/j.1525-139X.2007.00269.x","volume":"20","author":"MA Perazella","year":"2007","unstructured":"Perazella MA et al. (2007) Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 20: 179\u2013184","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR89","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jaad.2008.04.010","volume":"59","author":"A Khurana","year":"2008","unstructured":"Khurana A et al. (2008) Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors. J Am Acad Dermatol 59: 218\u2013224","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR90","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.0303-6987.2005.00365.x","volume":"32","author":"C Kucher","year":"2005","unstructured":"Kucher C et al. (2005) Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol 32: 484\u2013490","journal-title":"J Cutan Pathol"},{"key":"BFncpneph1040_CR91","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2559.2008.02947.x","volume":"52","author":"S Digby","year":"2008","unstructured":"Digby S et al. (2008) Nephrogenic systemic fibrosis: a histopathological study of eight cases of a recently described entity. Histopathology 52: 531\u2013534","journal-title":"Histopathology"},{"key":"BFncpneph1040_CR92","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncpneph0660","volume":"3","author":"JG Penfield","year":"2007","unstructured":"Penfield JG and Reilly RF Jr (2007) What nephrologists need to know about gadolinium. Nat Clin Pract Nephrol 3: 654\u2013668","journal-title":"Nat Clin Pract Nephrol"},{"key":"BFncpneph1040_CR93","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2133.2007.08335.x","volume":"158","author":"JL Abraham","year":"2008","unstructured":"Abraham JL et al. (2008) Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis. Br J Dermatol 158: 273\u2013280","journal-title":"Br J Dermatol"},{"key":"BFncpneph1040_CR94","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2133.2006.07652.x","volume":"156","author":"M Edward","year":"2007","unstructured":"Edward M et al. (2007) Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum. Br J Dermatol 156: 473\u2013479","journal-title":"Br J Dermatol"},{"key":"BFncpneph1040_CR95","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/path.2311","volume":"214","author":"M Edward","year":"2008","unstructured":"Edward M et al. (2008) Gadodiamide contrast agent 'activates' fibroblasts: a possible cause of nephrogenic systemic fibrosis. J Pathol 214: 584\u2013593","journal-title":"J Pathol"},{"key":"BFncpneph1040_CR96","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jaad.2008.02.038","volume":"58","author":"B Kelly","year":"2008","unstructured":"Kelly B et al. (2008) Nephrogenic systemic fibrosis is associated with transforming growth factor \u03b2 and Smad without evidence of renin\u2013angiotensin system involvement. J Am Acad Dermatol 58: 1025\u20131030","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR97","doi-asserted-by":"publisher","first-page":"968","DOI":"10.2215\/CJN.00100108","volume":"3","author":"JA Schroeder","year":"2008","unstructured":"Schroeder JA et al. (2008) Ultrastructural evidence of dermal gadolinium deposits in a patient with nephrogenic systemic fibrosis and endstage renal disease. Clin J Am Soc Nephrol 3: 968\u2013975","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph1040_CR98","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","volume":"56","author":"WA High","year":"2007","unstructured":"High WA et al. (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 21\u201326","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR99","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jaad.2007.01.022","volume":"56","author":"WA High","year":"2007","unstructured":"High WA et al. (2007) Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56: 710\u2013712","journal-title":"J Am Acad Dermatol"},{"key":"BFncpneph1040_CR100","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.2214\/AJR.07.2822","volume":"190","author":"CD Wiginton","year":"2008","unstructured":"Wiginton CD et al. (2008) Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue. AJR Am J Roentgenol 190: 1060\u20131068","journal-title":"AJR Am J Roentgenol"},{"key":"BFncpneph1040_CR101","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1093\/jmicro\/dfm020","volume":"56","author":"C Thakral","year":"2007","unstructured":"Thakral C et al. (2007) Automated scanning electron microscopy and X-ray microanalysis for in situ quantification of gadolinium deposits in skin. J Electron Microsc (Tokyo) 56: 181\u2013187","journal-title":"J Electron Microsc (Tokyo)"},{"key":"BFncpneph1040_CR102","doi-asserted-by":"publisher","first-page":"258","DOI":"10.2215\/CJN.03250906","volume":"2","author":"P Yerram","year":"2007","unstructured":"Yerram P et al. (2007) Nephrogenic systemic fibrosis: a mysterious disease in patients with renal failure\u2014role of gadolinium-based contrast media in causation and the beneficial effect of intravenous sodium thiosulfate. Clin J Am Soc Nephrol 2: 258\u2013263","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFncpneph1040_CR103","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/00000372-200306000-00004","volume":"25","author":"PW Baron","year":"2003","unstructured":"Baron PW et al. (2003) Nephrogenic fibrosing dermopathy after liver transplantation successfully treated with plasmapheresis. Am J Dermatopathol 25: 204\u2013209","journal-title":"Am J Dermatopathol"},{"key":"BFncpneph1040_CR104","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/archderm.143.8.1025","volume":"143","author":"H Richmond","year":"2007","unstructured":"Richmond H et al. (2007) Nephrogenic systemic fibrosis: relationship to gadolinium and response to photopheresis. Arch Dermatol 143: 1025\u20131030","journal-title":"Arch Dermatol"},{"key":"BFncpneph1040_CR105","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/ncpneph0373","volume":"3","author":"AS Weiss","year":"2007","unstructured":"Weiss AS et al. (2007) A case of nephrogenic fibrosing dermopathy\/nephrogenic systemic fibrosis. Nat Clin Pract Nephrol 3: 111\u2013115","journal-title":"Nat Clin Pract Nephrol"},{"key":"BFncpneph1040_CR106","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1002\/art.23696","volume":"58","author":"J Kay","year":"2008","unstructured":"Kay J et al. (2008) Imatinib mesylate treatment of nephrogenic systemic fibrosis. Arthritis Rheum 58: 2543\u20132548","journal-title":"Arthritis Rheum"},{"key":"BFncpneph1040_CR107","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/ki.2008.157","volume":"73","author":"D Prchal","year":"2008","unstructured":"Prchal D et al. (2008) Nephrogenic systemic fibrosis: the story unfolds. Kidney Int 73: 1135\u20131137","journal-title":"Kidney Int"},{"key":"BFncpneph1040_CR108","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1525-139X.2007.00405.x","volume":"21","author":"RA Rodby","year":"2008","unstructured":"Rodby RA (2008) Dialytic therapies to prevent NSF following gadolinium exposure in high-risk patients. Semin Dial 21: 145\u2013149","journal-title":"Semin Dial"},{"key":"BFncpneph1040_CR109","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1148\/radiol.2483071863","volume":"248","author":"MR Prince","year":"2008","unstructured":"Prince MR et al. (2008) Incidence of nephrogenic systemic fibrosis at two large medical centers. Radiology 248: 807\u2013816","journal-title":"Radiology"},{"key":"BFncpneph1040_CR110","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jacr.2007.08.018","volume":"5","author":"A Abu-Alfa","year":"2008","unstructured":"Abu-Alfa A (2008) The impact of NSF on the care of patients with kidney disease. J Am Coll Radiol 5: 45\u201352","journal-title":"J Am Coll Radiol"},{"key":"BFncpneph1040_CR111","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1365-2133.1996.tb03873.x","volume":"135","author":"CA Morton","year":"1996","unstructured":"Morton CA et al. (1996) Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 135: 671\u2013677","journal-title":"Br J Dermatol"},{"key":"BFncpneph1040_CR112","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1468-3083.2006.01571.x","volume":"20","author":"Y Saray","year":"2006","unstructured":"Saray Y et al. (2006) Acquired perforating dermatosis: clinicopathological features in twenty-two cases. J Eur Acad Dermatol Venereol 20: 679\u2013688","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFncpneph1040_CR113","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0272-6386(99)70123-X","volume":"34","author":"P Glynne","year":"1999","unstructured":"Glynne P et al. (1999) Bullous dermatoses in end-stage renal failure: porphyria or pseudoporphyria? Am J Kidney Dis 34: 155\u2013160","journal-title":"Am J Kidney Dis"},{"key":"BFncpneph1040_CR114","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1067\/mjd.2000.105504","volume":"42","author":"S Shieh","year":"2000","unstructured":"Shieh S et al. (2000) Management of porphyria cutanea tarda in the setting of chronic renal failure: a case report and review. J Am Acad Dermatol 42: 645\u2013652","journal-title":"J Am Acad Dermatol"}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpneph1040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph1040","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpneph1040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T23:39:06Z","timestamp":1710027546000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpneph1040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,3]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["BFncpneph1040"],"URL":"https:\/\/doi.org\/10.1038\/ncpneph1040","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,3]]}}}